富蘭克林坦伯頓全球投資系列-生技領航基金美元Z(acc)股
16.79美元0.56(3.23%)
2021/02/25更新
績效 / 1月0.93%
3月12.3%
1年33.77%
晨星評等-
淨值走勢
持股明細 / 風險評估
- 1.美國83.01%
- 2.英國4.63%
- 3.新興亞洲2.16%
- 4.加拿大2.07%
- 5.歐洲不包含歐元區1.40%
- 1.Gilead Sciences Inc6.40%
- 2.Vertex Pharmaceuticals Inc5.44%
- 3.Regeneron Pharmaceuticals Inc5.03%
- 4.Amgen Inc4.96%
- 5.Illumina Inc4.54%
- 1.美國83.01%
- 2.英國4.63%
- 3.新興亞洲2.16%
- 4.加拿大2.07%
- 5.歐洲不包含歐元區1.40%
- 1.Gilead Sciences Inc6.40%
- 2.Vertex Pharmaceuticals Inc5.44%
- 3.Regeneron Pharmaceuticals Inc5.03%
- 4.Amgen Inc4.96%
- 5.Illumina Inc4.54%